PACIFIC NORTHWEST PROSTATE CANCER SPORE

描述（由申请人提供）： 太平洋西北部前列腺癌SPORE是四个机构的协调努力，在前列腺癌研究和职业发展方面有很强的计划：1）弗雷德哈钦森癌症研究中心（FHCRC）; 2）华盛顿大学（UW）及其附属机构; 3）系统生物学研究所（ISB）;以及4）不列颠哥伦比亚省大学和温哥华综合医院前列腺中心和研究所。这三个位于西雅图和不列颠哥伦比亚省（BC）的机构拥有大量致力于前列腺癌（CAP）研究的研究人员和实验室。在这一背景下，已经存在大量的技术基础设施（例如，基因组学），强大的多学科专业知识（例如，分子生物学、生物化学、流行病学、遗传学、医学和放射肿瘤学、泌尿学），以及广泛的资源（例如，血清、DNA和组织库、CaP动物模型设施、CaP基因组阵列和CaP临床试验组织）。所有四个机构都有，并正在产生，增加翻译CaP研究项目的资源，并致力于为实现本SPORE的目标贡献大量资源。SPORE的目的不仅是执行所提出的研究项目，而且在更大的意义上形成“中央支持件”，以协调西北太平洋地区的翻译CaP研究的大型发展“马赛克”。 我们相信这些项目是创新和转化的。项目1是一项基于人群的研究，评估与CaP进展/死亡率相关的特定遗传多态性。项目2旨在表征播散性CaP细胞的分子改变（核型，转录），以影响患者的临床管理作为诊断和预后指标。项目3将确定从雄激素依赖性向雄激素非依赖性CaP转变的关键决定因素，并将在充分表征的临床前模型和临床试验中验证这些发现。项目4旨在扩大我们在CaP基因组学方面已经开展的广泛工作，并将确定肿瘤基因表达谱是否可以预测疾病的病程和对细胞毒性化疗的反应。 我们提出了五个核心来支持这些项目（管理，标本/组织，生物统计学，信息学和基因表达以及临床研究）。我们提出的职业发展和试点项目计划将大大美化和加强我们的前列腺癌研究的翻译方向，并扩大新的研究人员的机会。

DESCRIPTION (provided by applicant): The Pacific Northwest Prostate Cancer SPORE is a coordinated effort of four institutions with strong programs in prostate cancer research and career development: 1) the Fred Hutchinson Cancer Research Center (FHCRC); 2) the University of Washington (UW) and its affiliated institutions; 3) the Institute for Systems Biology (ISB); and 4) the University of British Columbia and the Prostate Center & Institute of Vancouver General Hospital. These three Seattle-based and the British Columbia (BC)-based institutions have a large number of investigators and laboratories dedicated to prostate cancer (CAP) research. Within this milieu, there already exists substantial technical infrastructure (e.g., genomics), strong multidisciplinary expertise (e.g., molecular biology, biochemistry, epidemiology, genetics, medical & radiation oncology, urology), and extensive resources (e.g., serum, DNA & tissue banks, CaP animal model facilities, CaP genomic arrays, and a CaP clinical trials organization). All four institutions have, and are in the process of generating, increasing resources for programs in translational CaP research and are committed to contributing significant resources toward the goals of this SPORE. The purpose of the SPORE is not only to perform the research projects proposed, but in a larger sense to form the "central supporting piece" to a large developing "mosaic" of coordinated translational CaP research in the Pacific Northwest. We believe the projects to be innovative and translational. Project 1 is a population-based study evaluating specific genetic polymorphisms in relation to CaP progression/mortality. Project 2 aims to characterize molecular alterations (karyotype, transcript) of disseminated CaP cells in the context of influencing the clinical management of patients as diagnostic and prognostic indicators. Project 3 will identify critical determinants of the transition from androgen-dependent to androgen-independent CaP, and will validate these findings in well-characterized pre-clinical models and clinical trials. Project 4 seeks to expand our already extensive work on the genomics of CaP and will determine if tumor gene expression profiles can predict the course of disease and response to cytotoxic chemotherapy. We have proposed five Cores in support of these projects (Administration, Specimen/Tissue, Biostatistics, Informatics & Gene Expression, and Clinical Research). The Career Development and Pilot Project Programs we propose will significantly embellish and strengthen the translational orientation of our prostate cancer research and expand opportunities for new investigators.